Healium Medical News
5 articles
growth-positive
HEALIUM MEDICAL ENTERS INTO STRATEGIC COOPERATION AGREEMENT WITH BRONCUS HOLDING CORPORATION (2216.HK)
Healium Medical has signed a new collaboration and licensing agreement with Broncus Holding Corporation to integrate Broncuss energy ablation with Healiums ultrasound technology for improved safety and efficacy in lung cancer treatment. The cooperation aims to create a single real-time tool that allows operators to target, treat, and monitor ablated tissues. This technology is expected to deliver more predictable treatment outcomes, increased safety and efficacy, and simplify the procedure flow for interventional pulmonologists. Healium previously signed a licensing agreement with Venus Medtech in the cardiology space. Healium Medical is an innovative Israeli medical-device company, while Broncus is a pioneer in the field of interventional pulmonology.
Partners
growth-positive
Venus Medtech Inc. Announces Formation of Joint Venture Company with Healium Medical Ltd | MarketScreener
Venus Medtech (Hangzhou) Inc. has formed a joint venture company called Renaly Ltd. with Healium Medical Ltd. The joint venture aims to introduce Healiums renal artery denervation (RDN) innovative system and develop, manufacture, and commercialize RDN products worldwide. Hypertension is a common chronic disease, and RDN treatment has shown safety and efficacy in treating uncontrolled or resistant hypertension. Healium specializes in researching and developing ultrasound energy capabilities. The joint venture will allow Venus Medtech to enter the intervention therapy market for hypertension, complementing its existing products in the field of structural heart disease. The partnership is expected to improve the market layout and provide better treatment options for unmet clinical needs.
Partners
growth-positive
Healium Medical Uses Ultrasonic Transducers from PI Ceramic for Award-Winning Catheter Ablation Procedure
Healium Medical, an Israeli start-up, has developed a transcatheter ultrasonic ablation procedure for the treatment of atrial fibrillation. The procedure, which uses transducers manufactured by PI Ceramic, won the ICI 2019 Innovation Award. The technology reduces the time required for treatment and improves the quality of the procedure through real-time monitoring. It also reduces the risk of injury. The company received prize money worth $100,000 sponsored by the Jon DeHaan Foundation.
Investment
growth-positive
https://www.jpost.com/israel-news/yokneams-healium-medical-wins-ici-award-610967
Ran Sela, CEO of Healium Medical, won the $100,000 Innovation Award at the Innovation in Cardiovascular Interventions Conference. The award recognizes the companys excellent innovation in medicine, particularly in the field of atrial fibrillation treatment. Healium Medical develops contactless guided ablation solutions to improve patient outcomes. The award provides international recognition and support for the development of ultrasound technology for better solutions in atrial fibrillation treatment. The conference was held from December 8-10.
PartnersInvestment
growth-positive
Researchers study non-invasive approach to monitor babies
University of Strathclyde researchers are studying a non-invasive, skin-based approach to monitor the blood chemistry of premature and sick babies to avoid invasive blood tests. The researchers aim to accurately measure glucose and lactate levels using a skin patch sensor. The trial is currently being conducted at the neonatal unit of the Royal Hospital for Children in Glasgow. The skin patch is expected to be cost-effective for manufacturing and may have future applications in adults. The commercialization of the technology will be handled by Strathclyde spin-out company Ohmedics.
Customers
